LINVEKINOGENE TRENIPLASMID
UNII 0P08SIO8FI

Substance Identification & Data

This profile provides standardized clinical and technical data for Linvekinogene Treniplasmid, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0P08SIO8FI.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2641647-12-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0P08SIO8FI
CAS Registry Number
2641647-12-1
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LINVEKINOGENE TRENIPLASMID
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
12196
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Linvekinogene Treniplasmid. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

LINVEKINOGENE TRENIPLASMID

Common Names & Synonyms

DNA (RECOMBINANT PLASMID VECTOR PCMVIECBAHUIL10F129S KANAMYCIN RESISTANCE GENE PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT PLUS HUMAN CYTOMEGALOVIRUS ENHANCER PLUS GALLUS GALLUS .BETA.-ACTIN PROMOTER PLUS GALLUS GALLUS .BETA.-ACTIN INTRON PLUS HUMAN (129-SERINE) INTERLEUKIN 10 PRECURSOR GENE PLUS SIMIAN VIRUS 40 POLYADENYLATION SIGNAL PLUS ADENO-ASSOCIATED VIRUS 2 INVERTED TERMINAL REPEAT-SPECIFYING)
LINVEKINOGENE TRENIPLASMID [INN]